GLP-1 Medications: Everything You Need to Know in 2026

GLP-1 receptor agonists have become the most talked-about weight loss medications in recent years. Originally developed for type 2 diabetes, drugs like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) have shown remarkable results for weight management, with clinical trials demonstrating 15-20% body weight reduction over 68 weeks.

So how do these medications actually work? GLP-1 agonists mimic a natural hormone called glucagon-like peptide-1, which your body produces after eating. They slow gastric emptying, reduce appetite, and improve insulin sensitivity. The result is that patients feel fuller faster, experience fewer cravings, and naturally eat less without the constant willpower battle that derails most diets.

The big question for most people is cost. Brand-name GLP-1 medications like Wegovy can run $1,300+ per month without insurance. However, the compounded medication market has changed the game entirely. Telehealth providers like CoreAge Rx, Hims, and Ro now offer compounded semaglutide starting at $129-199/month, making these medications accessible to a much wider population. If you're considering GLP-1 therapy, we recommend comparing providers on our comparison tool to find the best price and fit for your needs.